With a compound annual growth rate (CAGR) of 12% from 2023 to 2033, the global cancer vaccines market is predicted to be valued US$ 9 billion in 2023 and US$ 24.22 billion by 2033. The market for cancer vaccines expanded at a CAGR of 9% between 2018 and 2022. The cancer vaccine market is driven by factors such as increasing incidence of cancer, growing awareness about cancer vaccines, and...